Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Yilan Sun
Hangzhou Medical College - Zhejiang Provincial People's Hospital
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
190
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
The Efficacy and Safety of a Cap-Dependent Endonuclease Inhibitor, TG-1000, in Adolescent and Adult Outpatients with Acute Uncomplicated Influenza: A Multicenter, Randomized, Placebo-Controlled Phase III Trial
Number of pages: 23
Posted: 04 Dec 2024
Fang Jin
,
Feng Ye
,
Banghan Ding
, Yilan Sun,
Juan Yuan
,
Jinsai Shang
,
Lin Chen
,
Juan Huang
,
Junyan Hu
,
Hong Wang
,
Yu Zhang
,
Yan Xue-bing
,
Xinju Xu
,
Yufeng Luo
,
Chong-Yang Duan
,
Xiong Yu
and
Nan-Shan Zhong
Guangzhou Laboratory, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Guangzhou University of Traditional Chinese Medicine - Guangdong Provincial Hospital of Traditional Chinese Medicine, Hangzhou Medical College - Zhejiang Provincial People's Hospital, Xinxiang Medical University, Guangzhou Laboratory, Ningbo No. 2 Hospital, Guangzhou Respiratory Medicine Engineering Technology Co., Ltd., Guangzhou Medical University, Zhejiang Hospital, Nanyang Medical College, Nanjing Medical University, Henan Polytechnic University, Huizhou Central People's Hospital, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Joincare Pharmaceutical Industry Group Co Ltd and Guangzhou Medical University - State Key Laboratory of Respiratory Diseases
Downloads
190
(409,459)
View PDF
Download
Abstract:
influenza, antiviral, cap-dependent endonuclease inhibitor, TG-1000, phase III
Feedback